141 related articles for article (PubMed ID: 14512873)
1. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.
Nelson DR; Tu Z; Soldevila-Pico C; Abdelmalek M; Zhu H; Xu YL; Cabrera R; Liu C; Davis GL
Hepatology; 2003 Oct; 38(4):859-68. PubMed ID: 14512873
[TBL] [Abstract][Full Text] [Related]
2. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
[TBL] [Abstract][Full Text] [Related]
4. A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy.
Pockros PJ; Patel K; O'Brien C; Tong M; Smith C; Rustgi V; Carithers RL; McHutchison JG; Olek E; Debruin MF
Hepatology; 2003 Jun; 37(6):1368-74. PubMed ID: 12774016
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C.
Zeuzem S; Hopf U; Carreno V; Diago M; Shiffman M; Grüne S; Dudley FJ; Rakhit A; Rittweger K; Yap SH; Koff RS; Thomas HC
Hepatology; 1999 Apr; 29(4):1280-7. PubMed ID: 10094976
[TBL] [Abstract][Full Text] [Related]
8. Ribavirin in the treatment of hepatitis C.
Abonyi ME; Lakatos PL
Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection.
McHutchison JG; Giannelli G; Nyberg L; Blatt LM; Waite K; Mischkot P; Pianko S; Conrad A; Grint P
J Interferon Cytokine Res; 1999 Nov; 19(11):1265-70. PubMed ID: 10574619
[TBL] [Abstract][Full Text] [Related]
10. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
11. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
[TBL] [Abstract][Full Text] [Related]
12. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW
Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.
Torre F; Rossol S; Pelli N; Basso M; Delfino A; Picciotto A
Clin Exp Immunol; 2004 Jun; 136(3):507-12. PubMed ID: 15147353
[TBL] [Abstract][Full Text] [Related]
15. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C.
Pardo M; Castillo I; Oliva H; Fernández-Flores A; Bárcena R; de Peuter MA; Carreño V
Hepatology; 1997 Nov; 26(5):1318-21. PubMed ID: 9362378
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
[TBL] [Abstract][Full Text] [Related]
18. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
[TBL] [Abstract][Full Text] [Related]
19. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines.
Napoli J; Bishop GA; McGuinness PH; Painter DM; McCaughan GW
Hepatology; 1996 Oct; 24(4):759-65. PubMed ID: 8855173
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy.
Lawitz EJ; Hepburn MJ; Casey TJ
Am J Gastroenterol; 2004 Dec; 99(12):2359-64. PubMed ID: 15571583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
